AIkido Pharma Secures Interest in Databricks Inc.

Data and AI Company and a Pioneer of the Cutting-Edge Database Architecture

NEW YORK, May 12, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company, through a fund that owns the stock, has acquired an economic interest in privately held Databricks Inc.  (https://databricks.com/company/about-us).  The acquisition has been funded and closed, and the asset is on the Company's balance sheet.

Read more at prnewswire.com